Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma.

Liao R, Sun J, Wu H, Yi Y, Wang JX, He HW, Cai XY, Zhou J, Cheng YF, Fan J, Qiu SJ.

J Exp Clin Cancer Res. 2013 Jan 11;32:3. doi: 10.1186/1756-9966-32-3.

2.

Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma.

Pan QZ, Pan K, Zhao JJ, Chen JG, Li JJ, Lv L, Wang DD, Zheng HX, Jiang SS, Zhang XF, Xia JC.

Cancer Immunol Immunother. 2013 Nov;62(11):1675-85. doi: 10.1007/s00262-013-1471-1. Epub 2013 Sep 6.

PMID:
24061617
3.

Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.

Zhang JP, Yan J, Xu J, Pang XH, Chen MS, Li L, Wu C, Li SP, Zheng L.

J Hepatol. 2009 May;50(5):980-9. doi: 10.1016/j.jhep.2008.12.033. Epub 2009 Mar 11.

PMID:
19329213
4.

Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma.

Liao R, Sun TW, Yi Y, Wu H, Li YW, Wang JX, Zhou J, Shi YH, Cheng YF, Qiu SJ, Fan J.

Cancer Sci. 2012 Jun;103(6):984-92. doi: 10.1111/j.1349-7006.2012.02273.x. Epub 2012 Apr 19.

5.

Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.

Huang Y, Wang F, Wang Y, Zhu Z, Gao Y, Ma Z, Xu R, Du Z.

J Gastroenterol Hepatol. 2014 Apr;29(4):851-9. doi: 10.1111/jgh.12418.

PMID:
24303990
6.

Prevalence and clinical relevance of T-helper cells, Th17 and Th1, in hepatitis B virus-related hepatocellular carcinoma.

Yan J, Liu XL, Xiao G, Li NL, Deng YN, Han LZ, Yin LC, Ling LJ, Liu LX.

PLoS One. 2014 May 27;9(5):e96080. doi: 10.1371/journal.pone.0096080. eCollection 2014.

7.

Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection.

Ju MJ, Qiu SJ, Fan J, Xiao YS, Gao Q, Zhou J, Li YW, Tang ZY.

Am J Clin Pathol. 2009 Apr;131(4):498-510. doi: 10.1309/AJCP86PPBNGOHNNL.

8.

Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.

Liao R, Wu H, Yi Y, Wang JX, Cai XY, He HW, Cheng YF, Zhou J, Fan J, Sun J, Qiu SJ.

J Exp Clin Cancer Res. 2013 Apr 19;32:22. doi: 10.1186/1756-9966-32-22.

9.

Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients.

Zhao Q, Xiao X, Wu Y, Wei Y, Zhu LY, Zhou J, Kuang DM.

Eur J Immunol. 2011 Aug;41(8):2314-22. doi: 10.1002/eji.201041282. Epub 2011 Jul 4.

10.

Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells.

Kuang DM, Peng C, Zhao Q, Wu Y, Chen MS, Zheng L.

Hepatology. 2010 Jan;51(1):154-64. doi: 10.1002/hep.23291.

PMID:
19902483
11.

Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.

Li YW, Qiu SJ, Fan J, Zhou J, Gao Q, Xiao YS, Xu YF.

J Hepatol. 2011 Mar;54(3):497-505. doi: 10.1016/j.jhep.2010.07.044. Epub 2010 Oct 1.

PMID:
21112656
12.

Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection.

Wang JX, Yi Y, Li YW, Cai XY, He HW, Ni XC, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ.

BMC Cancer. 2014 Apr 28;14:297. doi: 10.1186/1471-2407-14-297.

13.

Elevated pretherapy serum IL17 in primary hepatocellular carcinoma patients correlate to increased risk of early recurrence after curative hepatectomy.

Wu J, Du J, Liu L, Li Q, Rong W, Wang L, Wang Y, Zang M, Wu Z, Zhang Y, Qu C.

PLoS One. 2012;7(12):e50035. doi: 10.1371/journal.pone.0050035. Epub 2012 Dec 5.

14.

Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma.

Xiang ZL, Zeng ZC, Tang ZY, Fan J, He J, Zeng HY, Zhu XD.

Oncologist. 2011;16(7):1028-39. doi: 10.1634/theoncologist.2010-0358. Epub 2011 Jun 10.

15.

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY.

J Clin Oncol. 2007 Jun 20;25(18):2586-93.

16.

Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients.

Kuang DM, Peng C, Zhao Q, Wu Y, Zhu LY, Wang J, Yin XY, Li L, Zheng L.

J Immunol. 2010 Aug 1;185(3):1544-9. doi: 10.4049/jimmunol.0904094. Epub 2010 Jun 25.

17.

Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection.

Chen KJ, Zhou L, Xie HY, Ahmed TE, Feng XW, Zheng SS.

Med Oncol. 2012 Sep;29(3):1817-26. doi: 10.1007/s12032-011-0006-x. Epub 2011 Jun 16.

PMID:
21678026
18.

Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma.

Wang F, Jing X, Li G, Wang T, Yang B, Zhu Z, Gao Y, Zhang Q, Yang Y, Wang Y, Wang P, Du Z.

Liver Int. 2012 Apr;32(4):644-55. doi: 10.1111/j.1478-3231.2011.02675.x. Epub 2011 Nov 28.

PMID:
22118340
19.

Increased circulating Th17 cells after transarterial chemoembolization correlate with improved survival in stage III hepatocellular carcinoma: a prospective study.

Liao Y, Wang B, Huang ZL, Shi M, Yu XJ, Zheng L, Li S, Li L.

PLoS One. 2013;8(4):e60444. doi: 10.1371/journal.pone.0060444. Epub 2013 Apr 2.

20.

IL-17 Producing Cells and RORγt mRNA Transcriptional Factor in Cirrhotic and HCC Egyptian Patients.

El Bassuoni MA, Soliman MA, El Megeed NA, Al Gazar A.

Egypt J Immunol. 2015;22(1):59-68.

PMID:
26415373
Items per page

Supplemental Content

Write to the Help Desk